Justification & Approval (J&A) for a Cost-Per-Test (CPT) Agreement to include reagents instrument/equipment compatible with Hologics SARS CoV-2 & Flu A/B reagents at BAMC
JustificationActive
This contract has been archived. It is preserved as a historical record.
This opportunity has closed
Similar active opportunities you might be interested in:
- 6650-VISN 8 Whole Blood Glucose Monitoring
- Sole Source - Urine Analyzers for NHCH
- Blood Bank Reagents - New Base Plus Four Option Year ContractDue: August 10, 2026
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in JBSA FT SAM HOUSTON, TX
- Industry: In-Vitro Diagnostic Substance Manufacturing
Contract Details
- Notice ID
- W81K00-25-P-A028
- Opportunity Type
- Justification
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEPT OF THE ARMY
- Office
- W40M MRC0 WEST
- Posted Date
- Friday, May 9, 2025
- Response Deadline
- Not specified
- PSC Code
- 6550
- Set-Aside
- Full & Open Competition
- Place of Performance
- JBSA FT SAM HOUSTON, TX, 78234-4504
- Status
- Active
Description
Attached is the Redacted Justification and Approval for a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment compatible with Hologics SARS CoV-2 & Flu A/B reagents at Brooke Army Medical Center in San Anotnio, Texas.
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing in JBSA FT SAM HOUSTON, TX.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
